RegenxBio gets positive interim data for eye disease treatment
October 15, 2019 at 14:48 PM EDT
The prospect of RegenxBio’s product could change the game for the roughly 2 million people who suffer from wet age-related macular degeneration in the U.S., Europe and Japan.
